@article{TLCR5062,
author = {José Moltó and Teresa Moran and Guillem Sirera and Bonaventura Clotet},
title = {Lung cancer in HIV-infected patients in the combination antiretroviral treatment era},
journal = {Translational Lung Cancer Research},
volume = {4},
number = {6},
year = {2015},
keywords = {},
abstract = {The advent of combination antiretroviral treatment (cART) has been followed by a decrease in HIV-associated morbidity and mortality, but also by an apparent increase in the incidence of non-AIDS-defining cancers (NADCs). The risk of lung cancer is substantially higher in HIV-infected patients than in the general population, in part due to aging and tobacco use, and it is the most frequent NADC. The management of lung cancer in HIV-infected patients has some peculiarities that need to be taken into account. This review focuses on the epidemiology, risk factors, and clinical management of lung cancer in HIV-infected patients. In addition, screening tools and future perspectives are also discussed.},
issn = {2226-4477}, url = {https://tlcr.amegroups.org/article/view/5062}
}